Stephen Oakeshott

Dr. Stephen Oakeshott is the Head of Infections and Immunity at the Medical Research Council (MRC), which is part of UK Research and Innovation (UKRI).12 In this role, he oversees research and funding initiatives related to infectious diseases and immune system disorders.

Dr. Oakeshott's responsibilities include:

1. Managing the Infections and Immunity Board (IIB), which aims to develop scientific understanding of human infectious diseases and immune system disorders.2

2. Overseeing strategic investments in vaccine development and research projects related to tackling infections.14

3. Representing the MRC in discussions about infectious disease research and public health initiatives.5

His work involves supporting a diverse portfolio of research spanning various areas, including:

• Human pathogens and their mechanisms of infection
• Diseases of the human immune system
• Conditions where altered immune regulation leads to pathology
• Early vaccine development
• Biomarker discovery and diagnostic tools for infections

Dr. Oakeshott has been involved in several significant research initiatives, such as:

• The Proactive Vaccinology Consortia, a £25 million investment to inform the design of better vaccines for SARS-CoV-2 and other diseases.2
• The UK research response to COVID-19, where the MRC played a major role.2
• Projects investigating avian influenza virus H5N1 and its potential risk to humans.2

His LinkedIn profile can be found under the username stephen-oakeshott-b0437417, as mentioned in the query.3